About this trial
Evaluate the Efficacy of Auricular Acupuncture Therapy via the Seirin Pyonex Needles in the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
Eligibility criteria
Qualifiers
Patients with breast cancer diagnosed with stage I-III;
Planned to receive 4 cycles of taxane chemotherapy and have not taken neurostable drugs within three months;
18 years old≤ age≤ 75 years old, female;
Subjects voluntarily participate in this trial and sign the informed consent form.
Disqualifiers
Patients who have had acupuncture treatment in the past;
After examination by a doctor, there is a local infection at or near the acupuncture site, which is not suitable for acupuncture.
Platelets< 50,000/μL;
Patients with CIPN≥1 grade 1 (NCI-CTCAE);
Trial design
Treatments tested in this trial
- Auricular acupuncture treatment
- Sham acupuncture group
Treatment groups
Locations
1Sponsors and collaborators
The First Affiliated Hospital with Nanjing Medical University
Lead sponsor